Shares of health-care companies ticked up as traders rotated into defensive areas of the market.
High-risk biotech stocks were weak while steadier concerns such as health insurer Humana were among stock-market gainers.
Continue Reading Below
The new chief executive of Israeli generic-drug making giant Teva Pharmaceutical Industries reshuffled leadership ranks and planned to combine its generic and specialty businesses as part of a turnaround plan.
Rob Curran, firstname.lastname@example.org
(END) Dow Jones Newswires
November 27, 2017 17:42 ET (22:42 GMT)